+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Stribild"

HIV Drugs and Injectables Market Report 2024-2034 - Product Thumbnail Image

HIV Drugs and Injectables Market Report 2024-2034

  • Report
  • July 2024
  • 288 Pages
  • Global
From
HIV Drugs Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

HIV Drugs Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Stribild is a combination antiretroviral medication used to treat HIV/AIDS. It is a single-tablet regimen containing four drugs: elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate. Stribild is used to treat HIV-1 infection in adults who have not taken antiretroviral medications before. It works by blocking the action of the virus in the body, preventing it from multiplying and reducing the amount of virus in the body. Stribild is part of a growing market of HIV/AIDS drugs, which includes other single-tablet regimens and combination therapies. These drugs are designed to help people living with HIV/AIDS manage their condition and reduce the risk of transmitting the virus to others. Companies in the Stribild market include Gilead Sciences, Inc., ViiV Healthcare, and Mylan N.V. Show Less Read more